Anebulo Pharmaceuticals, Inc. (ANEB)

USD 1.23

(-6.11%)

Market Cap (In USD)

31.89 Million

Revenue (In USD)

-

Net Income (In USD)

-8.2 Million

Avg. Volume

6666.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.23-3.3
PE
-
EPS
-
Beta Value
-1.01
ISIN
US0345691036
CUSIP
034569103
CIK
1815974
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Richard Anthony Cunningham
Employee Count
-
Website
https://www.anebulo.com
Ipo Date
2021-05-07
Details
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.